Innovation in Sepsis Management: Real-World Experience with MeMed BV in Emergency Care

Presented by: Diasorin

Speakers:

• David M. Engman, MD, PhD, Chairman Pathology Emeritus, Cedars-Sinai Medical Center
• David B. Hale, MD, PhD, Director of Emergency Medicine Associate Chief Medical Officer, ThedaCare, New London Hospital
• Jason Wilson, MD, PhD, CPE, FACEP, Faculty, Chief of Emergency Medicine at Tampa General Hospital

Time: Monday, October 5: 1:00pm – 1:45pm
(A meal or premium snacks will be provided, based on the time of day.)

Location: Exhibit Hall, Expert Theater 

Join emergency medicine leaders Dr. Jason Wilson (Tampa General Hospital) and Dr. David Hale (ThedaCare) as they share real-world experiences integrating MeMed BV into sepsis protocols and emergency department workflows. Through clinical case examples and implementation insights, the speakers will discuss how host-response diagnostics can help differentiate bacterial and viral infections, support admission and antibiotic decisions, improve patient stratification, and enhance management of patients with suspected sepsis.

The session will be moderated by David M. Engman, MD, PhD, Chairman Pathology Emeritus Cedars-Sinai Medical Center, who will provide expert perspective on the evolving role of innovative diagnostics in acute care. Attendees will learn how leading health systems are leveraging MeMed BV to optimize resource utilization while maintaining confidence in appropriate management of patients with suspected sepsis.